N-乙基-p-苯二胺二盐酸化物

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-乙基-p-苯二胺二盐酸化物
• 中文别名: N-乙基-1,4-苯二胺二盐酸盐；N-甲基-1,4-苯二胺,盐酸盐；N-甲基对苯二胺(盐酸盐)
• 英文名称: Methyl-p-phenylendiammonium dichloride
• 英文别名: (4-azaniumylphenyl)-methylazanium;dichloride
• 化学式: C7H12Cl2N2
• mdl: MFCD00051410
• 分子量: 195.09
• InChiKey: BXCWUHLEFQDLCY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.62
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  38
• 氢给体数：
  4
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-乙基-p-苯二胺二盐酸化物 、 氯甲酸苄酯 以98%的产率得到
  参考文献：
  名称：

  ALMEIDA, M. LURDES S.;GREHN, LEIF;RAGNARSSON, ULF, J. CHEM. SOC. PERKIN TRANS. PT 1,(1988) N 7, C. 1905-1911

  摘要：

  DOI：

文献信息

• Novel pyridine derivative and pyrimidine derivative
  申请人：Matsushima Tomohiro

  公开号：US20050277652A1

  公开（公告）日：2005-12-15

  A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents C 1-6 alkyl or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents C 1-6 alkyl or the like; V 1 represents oxygen or the like; V 2 represents oxygen or sulfur; W represents —NH— or the like; X represents —CH═, nitrogen or the like; and Y represents oxygen or the like.]

  以下化合物的分子式，其盐或前述水合物具有出色的肝细胞生长因子受体（HGFR）抑制活性，并表现出抗肿瘤活性、抑制血管生成活性和抑制癌转移活性。 [R 1 代表C 1-6 烷基或类似物；R 2 和R 3 代表氢；R 4 ，R 5 ，R 6 和R 7 可以相同也可以不同，每个代表氢、卤素、C 1-6 烷基或类似物；R 8 代表氢或类似物；R 9 代表C 1-6 烷基或类似物；V 1 代表氧或类似物；V 2 代表氧或硫；W代表—NH—或类似物；X代表—CH═、氮或类似物；Y代表氧或类似物。]
• Novel pyridine Derivative and Pyrimidine Derivative (1)
  申请人：Matsushima Tomohiro

  公开号：US20070270421A1

  公开（公告）日：2007-11-22

  A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents C 1-6 alkyl or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents C 1-6 alkyl or the like; V 1 represents oxygen or the like; V 2 represents oxygen or sulfur; W represents —NH— or the like; X represents —CH═, nitrogen or the like; and Y represents oxygen or the like.]

  以下化合物的公式，其盐或水合物具有出色的肝细胞生长因子受体（HGFR）抑制活性，并表现出抗肿瘤活性，抑制血管生成活性和癌症转移抑制活性。 [其中，R1代表C1-6烷基或类似物; R2和R3代表氢; R4，R5，R6和R7可能相同或不同，每个代表氢，卤素，C1-6烷基或类似物; R8代表氢或类似物; R9代表C1-6烷基或类似物; V1代表氧或类似物; V2代表氧或硫; W代表—NH—或类似物; X代表—CH═、氮或类似物; Y代表氧或类似物。]
• AZOMETHINE DIRECT DYES OR REDUCED PRECURSORS OF THESE DYES OBTAINED FROM 2-CHLORO-3-AMINO-6-METHYLPHENOL, AND HAIR DYEING METHOD STARTING FROM THESE DYES AND PRECURSORS
  申请人：Leduc Madeleine

  公开号：US20110041261A1

  公开（公告）日：2011-02-24

  The invention relates to the dyeing of keratinous fibres using azomethine direct dyes of formula (I) or reduced precursors of azomethine direct dyes of formula (II) obtained from 2-chloro-3-amino-6-methylphenol. A subject-matter of the invention is a dyeing composition comprising at least one chlorinated azomethine direct dye or one reduced precursor of a chlorinated azomethine direct dye, a method for dyeing keratinous fibres which employs the said composition and their uses in the dyeing of keratinous fibres. This composition makes it possible to obtain a particularly stable and consistent colouring.

  本发明涉及使用公式(I)的偶氮甲基直接染料或公式(II)的还原前体来染色角蛋白纤维。所述偶氮甲基直接染料或其还原前体是由2-氯-3-氨基-6-甲基苯酚制备而成。本发明的一种对象是染料组合物，包括至少一种氯化偶氮甲基直接染料或一种氯化偶氮甲基直接染料的还原前体，以及一种用于染色角蛋白纤维的方法，该方法采用上述组合物，并且该组合物在染色角蛋白纤维时能够获得特别稳定和一致的着色。
• Azomethine direct dyes or reduced precursors of these dyes obtained from 2-chloro-3-amino-6-methylphenol, and hair dyeing method starting from these dyes and precursors
  申请人：L'Oreal S.A.

  公开号：US08083809B2

  公开（公告）日：2011-12-27

  The invention relates to the dyeing of keratinous fibres using azomethine direct dyes of formula (I) or reduced precursors of azomethine direct dyes of formula (II) obtained from 2-chloro-3-amino-6-methylphenol. A subject-matter of the invention is a dyeing composition comprising at least one chlorinated azomethine direct dye or one reduced precursor of a chlorinated azomethine direct dye, a method for dyeing keratinous fibres which employs the said composition and their uses in the dyeing of keratinous fibres. This composition makes it possible to obtain a particularly stable and consistent colouring.

  本发明涉及使用公式（I）的偶氮甲烷直接染料或公式（II）的偶氮甲烷直接染料的还原前体，其从2-氯-3-氨基-6-甲基苯酚中获得，用于染色角蛋白纤维。本发明的一个主题是染料组合物，包括至少一种氯化偶氮甲烷直接染料或一种氯化偶氮甲烷直接染料的还原前体，以及一种用于染色角蛋白纤维的方法，该方法采用上述组合物及其在染色角蛋白纤维中的用途。该组合物可以获得特别稳定和一致的着色。
• NOVEL PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (2)
  申请人：Eisai Co., Ltd.

  公开号：EP1719763A1

  公开（公告）日：2006-11-08

  A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R1 represents C1-6 alkyl or the like; R2 and R3 represent hydrogen; R4, R5, R6, and R7 may be the same or different and each represents hydrogen, halogen, C1-6 alkyl or the like; R8 represents hydrogen or the like; R9b represents a 3- to 10-memberd non-aromatic heterocyclic group or the like; V1 represents oxygen or the like; V2 represents oxygen or sulfur; W represents -CH2- or the like; X represents -CH=, nitrogen or the like; and Y represents oxygen or the like.]

  下式代表的化合物、其盐或前述化合物的水合物具有极佳的肝细胞生长因子受体（HGFR）抑制活性，并具有抗肿瘤活性、血管生成抑制活性和癌症转移抑制活性。 [R1 代表 C1-6 烷基或类似物；R2 和 R3 代表氢； R4、R5、R6 和 R7 可以相同或不同，各自代表氢、卤素、C1-6 烷基或类似物；R8 代表氢或类似物；R9b 代表 3 至 10 个成员的非芳香杂环基团或类似物；V1 代表氧或类似物；V2 代表氧或硫；W 代表 -CH2- 或类似物；X 代表 -CH=、氮或类似物；Y 代表氧或类似物。］